Stay updated with breaking news from Sellas Life Sciences. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
SHANGHAI - GenFleet Therapeutics, a clinical-stage biotechnology company developing cutting-edge therapies in oncology and immunology, announced that U.S. Food and Drug Administration has recently...
GenFleet Therapeutics has received the US Food and Drug Administration (FDA) designations for its drug candidate SLS009 (GFH009).
/PRNewswire/ -- GenFleet Therapeutics, a clinical-stage biotechnology company developing cutting-edge therapies in oncology and immunology, announced that U.S....
Sellas Life Sciences (NASDAQ:SLS) stock is taking a beating on Thursday after the late-stage clinical biopharmaceutical company announced a proposed public…
Shares of SELLAS Life Sciences Group, Inc. (SLS), a late-stage clinical biopharmaceutical company, tumbled on Thursday after the announcement of the pricing of a share offering of 12 million shares and accompanying warrants at $0.